本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Tscan Therapeutics, Inc.

1.81
+0.04002.26%
盤後1.840.0300+1.66%19:52 EDT
成交量:30.46萬
成交額:54.92萬
市值:1.02億
市盈率:-0.78
高:1.86
開:1.79
低:1.76
收:1.77
資料載入中...
2021/07/28

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/07/22

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/07/20

重要事件披露

8-K - Current report
2021/07/16

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/07/16

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/07/14

SEC問詢函

CORRESP [Cover] - Correspondence
2021/07/13

SEC問詢函

CORRESP [Cover] - Correspondence
2021/07/13

SEC問詢函

CORRESP [Cover] - Correspondence
2021/07/12

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/05/14

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/05/05

SEC問詢函

CORRESP [Cover] - Correspondence
2021/05/05

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/04/30

SEC問詢函

CORRESP [Cover] - Correspondence
2021/04/30

SEC問詢函

CORRESP [Cover] - Correspondence
2021/04/30

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/04/23

SEC問詢函

CORRESP [Cover] - Correspondence
2021/04/23

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2018/11/05

交易所摘牌聲明

2018/06/04

SEC問詢函

2018/06/04

SEC問詢函